lockdown in many countries around the world including Thailand. But the negative impact on domestic consumption, manufacturing and export sectors persisted in this quarter, despite improvement from the
of local businesses, their workers as well as increased household debt. Moreover, recovery on tourist and export sectors, key engines for Thai economy, still mainly depend on large scale vaccination in
severe outbreaks in Q2- 2021, which impacted a wide range of economic activities, particularly the tourism and service sectors with more stringent disease-control measures. However, this control measure is
severe outbreaks in Q2- 2021, which impacted a wide range of economic activities, particularly the tourism and service sectors with more stringent disease-control measures. However, this control measure is
recovery of some business sectors, including the export sector that continued to decline due to the economic slowdown in Thailand's major trading partners. This may affect the ability to pay of customers in
situation improved, employees of public and private sectors are returning to the workplace which led to an increase in IT equipment demand. Additionally, the Company has proactively expanded its corporate
situation. As the COVID-19 situation improved, employees of public and private sectors are returning to the workplace which led to an increase in IT equipment demand. Additionally, the Company has proactively
markets went into a tailspin, whereas turbulence was seen in manufacturing, service and tourism sectors, which in turn dampened domestic spending sentiment. The situation adversely affected the government’s
Opportunity รายละเอ ียดของกองทนุ UBS (Lux) IS - China A Opportunity ชื>อกองทนุหลกั UBS (Lux) Investment SICAV - China A Opportunity ISIN Code LU1676119669 Bloomberg Ticker UBCIA1A LX สกลุเงิน ดอลลารส์หรฐัฯ (USD
• การลงทุนในหน่วยลงทุนมิใช่การฝากเงินและมีความเสี่ยงของการลงทุน ผู้ลงทุนควรลงทุนในกองทุนเปิดแมกซ์ 1 กองทุนเปิดไทยพาณิชย์ Genomic Revolution: SCBGENOME หนังสือชี้ชวนส่วนข้อมูลกองทุนรวม กองทุนเปิดไทยพาณิชย์ Genomic Revolution SCB Genomic Revolution (SCBGENOME) กองทุนนี้ลงทนุกระจุกตัวในหมวดอตุสาหกรรม Health Care จึงมีความเสี่ยงที่ผู้ลงทนุอาจสูญเสียเงินลงทนุจำนวนมาก ▪ กองทุนมีนโยบายเน้นลงทุนในหน่วยลงทุนของกองทุนรวมต่างประเทศเพียงกองทุนเดียว (Feeder Fund) ได้แก่ ARK Genomic Revolution ETF (ARKG) (กอง...